75 related articles for article (PubMed ID: 25667475)
21. Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma.
Jensen HK; Donskov F; Marcussen N; Nordsmark M; Lundbeck F; von der Maase H
J Clin Oncol; 2009 Oct; 27(28):4709-17. PubMed ID: 19720929
[TBL] [Abstract][Full Text] [Related]
22. VEGF expression and response to sunitinib in patients with metastatic clear cell renal cell carcinoma.
Minardi D; Lucarini G; Santoni M; Mazzucchelli R; Burattini L; Pistelli M; Bianconi M; Di Primio R; Scartozzi M; Montironi R; Cascinu S; Muzzonigro G
Anticancer Res; 2013 Nov; 33(11):5017-22. PubMed ID: 24222145
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors in patients with advanced renal cell carcinoma.
Muriel López C; Esteban E; Berros JP; Pardo P; Astudillo A; Izquierdo M; Crespo G; Sanmamed M; Fonseca PJ; Martínez-Camblor P
Clin Genitourin Cancer; 2012 Dec; 10(4):262-70. PubMed ID: 22959659
[TBL] [Abstract][Full Text] [Related]
24. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of vascular endothelial growth factor expression in clear cell renal cell carcinoma.
Djordjevic G; Mozetic V; Mozetic DV; Licul V; Ilijas KM; Mustac E; Oguic R; Fuckar Z; Jonjic N
Pathol Res Pract; 2007; 203(2):99-106. PubMed ID: 17270362
[TBL] [Abstract][Full Text] [Related]
26. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in esophageal adenocarcinoma.
Saad RS; El-Gohary Y; Memari E; Liu YL; Silverman JF
Hum Pathol; 2005 Sep; 36(9):955-61. PubMed ID: 16153457
[TBL] [Abstract][Full Text] [Related]
27. Pathologic T1 clear cell renal cell carcinoma: insulin-like growth factor-I receptor expression and disease-specific survival.
Parker AS; Cheville JC; Blute ML; Igel T; Lohse CM; Cerhan JR
Cancer; 2004 Jun; 100(12):2577-82. PubMed ID: 15197799
[TBL] [Abstract][Full Text] [Related]
28. Identification and validation of TGFBI as a promising prognosis marker of clear cell renal cell carcinoma.
Lebdai S; Verhoest G; Parikh H; Jacquet SF; Bensalah K; Chautard D; Rioux Leclercq N; Azzouzi AR; Bigot P
Urol Oncol; 2015 Feb; 33(2):69.e11-8. PubMed ID: 25035170
[TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factor - its relation to neovascularization and their significance as prognostic factors in renal cell carcinoma.
Song KH; Song J; Jeong GB; Kim JM; Jung SH; Song J
Yonsei Med J; 2001 Oct; 42(5):539-46. PubMed ID: 11675683
[TBL] [Abstract][Full Text] [Related]
30. Molecular biomarkers for advanced renal cell carcinoma: implications for prognosis and therapy.
Kim HS; Kim WS; Park SH; Jung CW; Choi HY; Lee HM; Jeon SS; Ha H; Hwang IG; Lee S; Lim HY
Urol Oncol; 2010; 28(2):157-63. PubMed ID: 18976937
[TBL] [Abstract][Full Text] [Related]
31. High Jagged1 expression predicts poor outcome in clear cell renal cell carcinoma.
Wu K; Xu L; Zhang L; Lin Z; Hou J
Jpn J Clin Oncol; 2011 Mar; 41(3):411-6. PubMed ID: 21062756
[TBL] [Abstract][Full Text] [Related]
32. Vascular cell adhesion molecule 1 predicts cancer-free survival in clear cell renal carcinoma patients.
Shioi K; Komiya A; Hattori K; Huang Y; Sano F; Murakami T; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M
Clin Cancer Res; 2006 Dec; 12(24):7339-46. PubMed ID: 17189405
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemistry to enhance prognostic allocation and guide decision-making of patients with advanced urothelial cancer receiving first-line chemotherapy.
Necchi A; Giannatempo P; Paolini B; Lo Vullo S; Marongiu M; Farè E; Raggi D; Nicolai N; Piva L; Catanzaro M; Biasoni D; Torelli T; Stagni S; Maffezzini M; Gianni AM; De Braud F; Mariani L; Sonpavde G; Colecchia M; Salvioni R
Clin Genitourin Cancer; 2015 Apr; 13(2):171-7.e1. PubMed ID: 25193365
[TBL] [Abstract][Full Text] [Related]
34. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
35. Significance of amyloid A immunoexpression in the prognosis of renal cell carcinoma.
Oz Atalay F; Aytac Vuruskan B; Vuruskan H
APMIS; 2016 Apr; 124(4):257-62. PubMed ID: 26750935
[TBL] [Abstract][Full Text] [Related]
36. Prognostic impact of fibroblast growth factor 2 in non-small cell lung cancer: coexpression with VEGFR-3 and PDGF-B predicts poor survival.
Donnem T; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM
J Thorac Oncol; 2009 May; 4(5):578-85. PubMed ID: 19318994
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y
Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370
[TBL] [Abstract][Full Text] [Related]
38. The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival.
Zubac DP; Bostad L; Kihl B; Seidal T; Wentzel-Larsen T; Haukaas SA
J Urol; 2009 Nov; 182(5):2144-9. PubMed ID: 19758660
[TBL] [Abstract][Full Text] [Related]
39. Claudins as prognostic factors for renal cell cancer.
Virman J; Soini Y; Kujala P; Luukkaala T; Salminen T; Sunela K; Kellokumpu-Lehtinen PL
Anticancer Res; 2014 Aug; 34(8):4181-7. PubMed ID: 25075044
[TBL] [Abstract][Full Text] [Related]
40. Stem cell markers aldehyde dehydrogenase type 1 and nestin expressions in renal cell cancer.
Ozbek E; Calik G; Otunctemur A; Aliskan T; Cakir S; Dursun M; Somay A
Arch Ital Urol Androl; 2012 Mar; 84(1):7-11. PubMed ID: 22649953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]